Steven P. Gelone - 30 Sep 2021 Form 4 Insider Report for Nabriva Therapeutics plc (NBRVF)

Role
President and COO, Director
Signature
/s/ J. Christopher Naftzger, by power of attorney
Issuer symbol
NBRVF
Transactions as of
30 Sep 2021
Transactions value $
-$75
Form type
4
Filing time
04 Oct 2021, 16:09:54 UTC
Previous filing
08 Sep 2021
Next filing
08 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBRVF Ordinary Shares Tax liability -$75 -63 -0.02% $1.19 367K 30 Sep 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These ordinary shares were withheld by the Issuer in order to satisfy tax withholding obligations upon the vesting of certain restricted share units.

Remarks:

Exhibit Index: 24.1 - Power of Attorney